ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.2150
-0.0060 (-2.71%)
At close: May 5, 2026
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $1.74 million as of May 6, 2026. Its market cap has decreased by -31.30% in one year.
Market Cap
1.74M
Enterprise Value
1.64M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.22
Market Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from 95.47M to 1.74M, a decrease of -98.18%. That is a compound annual growth rate of -61.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 1.74M | 60.93% |
| Dec 31, 2025 | 1.08M | -59.32% |
| Dec 31, 2024 | 2.66M | -43.66% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
| Feb 10, 2022 | 95.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProtoKinetix | 2.21M |
| AXIM Biotechnologies | 1.90M |
| LakeShore Biopharma | 1.81M |
| Avenue Therapeutics | 1.71M |
| Enzolytics | 1.69M |
| Clearside Biomedical | 1.67M |
| Hepion Pharmaceuticals | 1.55M |
| Agentix | 1.49M |